Comparison of transcutaneous tibial nerve stimulation versus percutaneous tibial nerve stimulation in category IIIB chronic prostatitis/chronic pelvic pain syndrome: A randomized prospective trial

被引:5
|
作者
Sevim, Mehmet [1 ]
Alkis, Okan [1 ]
Kartal, Ibrahim Gueven [1 ]
Kazan, Huseyin Ozgur [1 ]
Ivelik, Halil Ibrahim [1 ]
Aras, Bekir [1 ]
Kabay, Sahin [2 ]
机构
[1] Kutahya Hlth Sci Univ, Fac Med, Dept Urol, Kutahya, Turkiye
[2] Altinbas Univ, Fac Med, Dept Urol, Istanbul, Turkiye
关键词
chronic pelvic pain syndrome; chronic prostatitis; percutaneous tibial nerve stimulation; transcutaneous tibial nerve stimulation; SACRAL NEUROMODULATION; OVERACTIVE BLADDER; SYMPTOM INDEX; MANAGEMENT; EFFICIENCY; URINARY;
D O I
10.1002/pros.24513
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BackgroundChronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) is a heterogenous condition that impacts the Quality of life severely, and it has multimodal complex treatment options. We aimed to compare the efficacy of two well-described neuromodulation therapies, transcutaneous tibial nerve stimulation (TTNS) versus percutaneous tibial nerve stimulation (PTNS) in the treatment of category IIIB CP/CPPS. MethodsThis study was designed as a randomized prospective clinical trial. We randomized category IIIB CP/CPPS patients into two treatment groups as TTNS and PTNS groups. Category IIIB CP/CPPS was diagnosed by two or four-glass Meares-Stamey test. All patients included in our study were antibiotic/anti-inflammatory resistant. Transcutaneous and percutaneous treatments were applied 30 min sessions for 12 weeks. Patients were evaluated by Turkish-validated National Health Institute Chronic Prostatitis Symptom Index (NIH-CPSI) and visual analogue scale (VAS) initially and after treatment. Treatment success was evaluated within each group and also compared with each other. ResultsA total of 38 patients in the TTNS group and 42 patients in the PTNS group were included in the final analysis. The mean VAS scores of the TTNS group were lower than the PTNS group initially (7.11 and 7.43, respectively), (p = 0.03). The pretreatment NIH-CPSI scores were similar between groups (p = 0.07). VAS scores, total NIH-CPSI, NIH-CPSI micturation, NIH-CPSI pain, and NIH-CPSI QoL scores decreased significantly at the end of the treatment in both groups. We found a significantly higher VAS and NIH-CPSI scores decrease in the PTNS group compared to the TTNS group (p < 0.01). ConclusionBoth PTNS and TTNS are effective treatment methods in category IIIB CP/CPPS. Comparing the two methods, PTNS provided a higher level of improvement in terms of pain and quality of life.
引用
收藏
页码:751 / 758
页数:8
相关论文
共 50 条
  • [21] Clinical efficacy of roxithromycin in men with chronic prostatitis/chronic pelvic pain syndrome in comparison with ciprofloxacin and aceclofenac: A prospective, randomized, multicenter pilot trial
    Choe, Hyun-Sop
    Lee, Seung-Ju
    Han, Chang Hee
    Shim, Bong Suk
    Cho, Yong-Hyun
    JOURNAL OF INFECTION AND CHEMOTHERAPY, 2014, 20 (1-2) : 20 - 25
  • [22] Acupuncture for chronic prostatitis/chronic pelvic pain syndrome: study protocol for a randomized controlled trial
    Qin, Zongshi
    Liu, Yan
    Zhou, Kehua
    Wu, Jiani
    Pang, Ran
    Li, Ning
    Xu, Chang
    Kwong, Joey S. W.
    Liu, Zhishun
    TRIALS, 2017, 18
  • [23] Percutaneous tibial nerve stimulation for the treatment of interstitial cystitis/bladder pain syndrome: a pilot study
    Sudol, Neha T.
    Guaderrama, Noelani
    Adams-Piper, Emily
    Whitcomb, Emily
    Lane, Felicia
    INTERNATIONAL UROGYNECOLOGY JOURNAL, 2021, 32 (10) : 2757 - 2764
  • [24] A Randomized Controlled Trial of Percutaneous Tibial Nerve Stimulation in the Treatment of Female Sexual Dysfunction
    Huang, Zhenyue
    Far, Sina Mehraban
    Aronov, Jonathan
    Harandi, Arshia Aalami
    Hwang, Kuemin
    Zhang, Xiaoyue
    Talanki, Varun
    Ruan, Heng
    Cohen, Tal Meir
    Weissbart, Steven
    Tam, Justina
    Kim, Jason
    NEUROUROLOGY AND URODYNAMICS, 2025, : 908 - 913
  • [25] Randomized Trial of Percutaneous Tibial Nerve Stimulation Versus Sham Efficacy in the Treatment of Overactive Bladder Syndrome: Results From the SUmiT Trial
    Peters, Kenneth M.
    Carrico, Donna J.
    Perez-Marrero, Ramon A.
    Khan, Ansar U.
    Wooldridge, Leslie S.
    Davis, Gregory L.
    MacDiarmid, Scott A.
    JOURNAL OF UROLOGY, 2010, 183 (04) : 1438 - 1443
  • [26] Transcutaneous tibial nerve stimulation in the overactive bladder syndrome in patients with Parkinson's syndromes
    Ohannessian, A.
    Kabore, F. A.
    Agostini, A.
    Aurier, K. Lenne
    Witjas, T.
    Azulay, J. -P.
    Karsenty, G.
    PROGRES EN UROLOGIE, 2013, 23 (11): : 936 - 939
  • [27] Transcutaneous tibial nerve home stimulation for overactive bladder in women with Parkinson's disease: A randomized clinical trial
    Araujo, Tatiane G.
    Schmidt, Adriana P.
    Sanches, Paulo R. S.
    Silva Junior, Danton P.
    Rieder, Carlos R. M.
    Ramos, Jose G. L.
    NEUROUROLOGY AND URODYNAMICS, 2021, 40 (01) : 538 - 548
  • [28] Evaluation of Percutaneous Tibial Nerve Stimulation for Treatment of Refractory Painful Bladder Syndrome
    Ragab, Maged M.
    Tawfik, Ahmad M.
    El-Enen, Mohamed Abo
    Elnady, Mohamed
    El-Gamal, Osama M.
    El-Kordy, Mohamed
    Gameel, Tarek
    Rasheed, Mohamed
    UROLOGY, 2015, 86 (04) : 707 - 711
  • [29] Comparison of transcutaneous tibial nerve stimulation (TTNS) protocols for women with refractory overactive bladder (OAB): A prospective randomised trial
    Alkis, Okan
    Sevim, Mehmet
    Kartal, Ibrahim Guven
    Baser, Aykut
    Ivelik, Halil Ibrahim
    Aras, Bekir
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2021, 75 (09)
  • [30] Prospective and randomized comparison of electrical stimulation of the posterior tibial nerve versus oxybutynin versus their combination for treatment of women with overactive bladder syndrome
    Souto, Sophia C.
    Reis, Leonardo O.
    Palma, Thais
    Palma, Paulo
    Denardi, Fernandes
    WORLD JOURNAL OF UROLOGY, 2014, 32 (01) : 179 - 184